Kohei Takubo

Title: Kohei Takubo: Innovator in Tumor Detection Technologies

Introduction

Kohei Takubo is a prominent inventor based in Ryugasaki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of malignant tumor cells. With a total of five patents to his name, Takubo's work is at the forefront of cancer research and detection technologies.

Latest Patents

Among his latest patents, Takubo has developed a method for detecting malignant tumor cells. This innovative detection method involves measuring a protein marker expressed on the surface of malignant tumor cells. Specifically, it includes measuring LR11 on the cell surface in a sample to be tested. Another notable patent is his method for immunologically measuring soluble LR11. This method provides a simple and accurate assay of soluble LR11 present in biological samples, such as serum, without the need for isolation. The method is characterized by treating the sample with specific surfactants to enhance the assay's effectiveness.

Career Highlights

Kohei Takubo is associated with Sekisui Medical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on early cancer detection and treatment.

Collaborations

Takubo has collaborated with notable colleagues, including Hiroyuki Ebinuma and Isamu Fukamachi. These partnerships have contributed to the success and innovation of his projects.

Conclusion

Kohei Takubo's contributions to the field of tumor detection are invaluable. His innovative methods and collaborative efforts continue to push the boundaries of medical diagnostics.